抗血栓形成策略的新范式：迈向心血管医学未来的飞跃。
New Paradigms in Antithrombotic Strategies: A Leap into the Future of Cardiovascular Medicine.
作者信息
Romiti Giulio Francesco
机构信息
Department of Translational and Precision Medicine, Sapienza-University of Rome, 00161 Rome, Italy.
出版信息
J Clin Med. 2022 May 10;11(10):2693. doi: 10.3390/jcm11102693.
Abstract
During the last decades, significant improvements have changed the landscape of antithrombotic treatment strategies and, more generally, the treatment of thrombotic and cardiovascular diseases [...].
摘要
在过去几十年中，显著的进步改变了抗血栓治疗策略的格局，更广泛地说，改变了血栓性和心血管疾病的治疗格局[...]。
相似文献
1
New Paradigms in Antithrombotic Strategies: A Leap into the Future of Cardiovascular Medicine.抗血栓形成策略的新范式：迈向心血管医学未来的飞跃。
J Clin Med. 2022 May 10;11(10):2693. doi: 10.3390/jcm11102693.
2
Prevention of thrombotic disorders by antithrombotic diet and exercise: evidence by using global thrombosis tests.通过抗血栓饮食和运动预防血栓形成疾病：使用全球血栓形成检测的证据
Future Sci OA. 2018 Jan 24;4(4):FSO285. doi: 10.4155/fsoa-2017-0104. eCollection 2018 Apr.
3
Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats.肝硬化患者的传统及新型抗血栓药物——可能性与注意事项。
J Hepatol. 2013 Aug;59(2):358-66. doi: 10.1016/j.jhep.2013.03.027. Epub 2013 Mar 30.
4
Natural Products Towards the Discovery of Potential Future Antithrombotic Drugs.天然产物助力未来潜在抗血栓药物的发现。
Curr Pharm Des. 2016;22(20):2926-46. doi: 10.2174/1381612822666160307150454.
5
Interactions of antithrombotic herbal medicines with Western cardiovascular drugs.抗血栓草药与心血管西药的相互作用。
Pharmacol Res. 2020 Sep;159:104963. doi: 10.1016/j.phrs.2020.104963. Epub 2020 Jun 1.
6
Emerging nanotherapeutics for antithrombotic treatment.用于抗血栓治疗的新型纳米疗法。
Biomaterials. 2020 Oct;255:120200. doi: 10.1016/j.biomaterials.2020.120200. Epub 2020 Jun 12.
7
Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.非甾体抗炎药（NSAIDs）的使用与心梗后接受抗血栓治疗的患者出血和心血管事件风险的关联。
JAMA. 2015 Feb 24;313(8):805-14. doi: 10.1001/jama.2015.0809.
8
Current and Future Insights for Optimizing Antithrombotic Therapy to Reduce the Burden of Cardiovascular Ischemic Events in Patients with Acute Coronary Syndrome.优化抗栓治疗以减轻急性冠状动脉综合征患者心血管缺血事件负担的当前及未来见解
J Clin Med. 2022 Sep 23;11(19):5605. doi: 10.3390/jcm11195605.
9
Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus.抗血栓治疗在冠状动脉疾病和糖尿病患者中的应用：降低动脉粥样硬化性心血管疾病风险。
Circulation. 2020 Dec;142(22):2172-2188. doi: 10.1161/CIRCULATIONAHA.120.045465. Epub 2020 Nov 30.
10
Management of antithrombotic treatment and bleeding disorders in patients requiring venous access devices: A systematic review and a GAVeCeLT consensus statement.需要静脉通路装置的患者的抗血栓治疗和出血性疾病的管理：系统评价和 GAVeCeLT 共识声明。
J Vasc Access. 2022 Jul;23(4):660-671. doi: 10.1177/11297298211072407. Epub 2022 May 9.
本文引用的文献
1
Temporal trends and patterns in atrial fibrillation incidence: A population-based study of 3·4 million individuals.心房颤动发病率的时间趋势和模式：一项基于340万个体的人群研究。
Lancet Reg Health Eur. 2022 Apr 25;17:100386. doi: 10.1016/j.lanepe.2022.100386. eCollection 2022 Jun.
2
Prevalence of New-Onset Atrial Fibrillation and Associated Outcomes in Patients with Sepsis: A Systematic Review and Meta-Analysis.脓毒症患者新发房颤的患病率及相关结局：一项系统评价和荟萃分析
J Pers Med. 2022 Mar 30;12(4):547. doi: 10.3390/jpm12040547.
3
Prevalence and Rate of Resolution of Left Atrial Thrombus in Patients with Non-Valvular Atrial Fibrillation: A Two-Center Retrospective Real-World Study.非瓣膜性心房颤动患者左心房血栓的患病率及溶解率：一项双中心回顾性真实世界研究
J Clin Med. 2022 Mar 10;11(6):1520. doi: 10.3390/jcm11061520.
4
Anticoagulation Prior to COVID-19 Infection Has No Impact on 6 Months Mortality: A Propensity Score-Matched Cohort Study.新冠病毒感染前的抗凝治疗对6个月死亡率无影响：一项倾向评分匹配队列研究。
J Clin Med. 2022 Jan 12;11(2):352. doi: 10.3390/jcm11020352.
5
Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Non-Valvular Atrial Fibrillation Patients: Results of A Real-World Study in a Metropolitan Area of Northern Italy.非维生素K口服抗凝剂在非瓣膜性心房颤动患者中的有效性和安全性：意大利北部一个大都市地区的真实世界研究结果
J Clin Med. 2021 Sep 30;10(19):4536. doi: 10.3390/jcm10194536.
6
A Review of Current and Future Antithrombotic Strategies in Surgical Patients-Leaving the Graduated Compression Stockings Behind?外科患者当前及未来抗栓策略综述——摒弃分级加压弹力袜？
J Clin Med. 2021 Sep 22;10(19):4294. doi: 10.3390/jcm10194294.
7
Abelacimab for Prevention of Venous Thromboembolism.Abelacimab 用于预防静脉血栓栓塞。
N Engl J Med. 2021 Aug 12;385(7):609-617. doi: 10.1056/NEJMoa2105872. Epub 2021 Jul 19.
8
Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis.COVID-19住院患者中心房颤动的患病率及影响：一项系统评价和荟萃分析
J Clin Med. 2021 Jun 4;10(11):2490. doi: 10.3390/jcm10112490.
9
Inappropriate Use of Oral Antithrombotic Combinations in an Outpatient Setting and Associated Risks: A French Nationwide Cohort Study.门诊环境中口服抗血栓药物联合使用不当及其相关风险：一项法国全国性队列研究。
J Clin Med. 2021 May 27;10(11):2367. doi: 10.3390/jcm10112367.
10
Interplay between inflammation and thrombosis in cardiovascular pathology.心血管病理学中的炎症与血栓形成的相互作用。
Nat Rev Cardiol. 2021 Sep;18(9):666-682. doi: 10.1038/s41569-021-00552-1. Epub 2021 May 6.
Zotero 插件